Clinical Trials
- Children's Health, Men's Health, Women's Health, Immune System
Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and Children
- Ages2 years and older
- GenderBoth
- Date12/05/2019
- Immune System
Study of Adult Patients Receiving DUPIXENT® for Atopic Dermatitis (AD) (PROSE)
- Ages18 years and older
- GenderBoth
- Date07/15/2019
- Immune System
RESET Trial - Part 1 (Followed by Reset Trial - Part 2) - A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS)
- Ages3 years and older
- GenderBoth
- Date08/19/2018